Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | HER2 BATs |
| Synonyms | |
| Therapy Description |
HER2 BATs are activated T cells armed with bispecific antibodies targeting both CD3 and Erbb2 (Her2), which specifically kills Erbb2 (Her2)-positive cancer cells (PMID: 11359672). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| HER2 BATs | HER2 BATs are activated T cells armed with bispecific antibodies targeting both CD3 and Erbb2 (Her2), which specifically kills Erbb2 (Her2)-positive cancer cells (PMID: 11359672). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03661424 | Phase I | HER2 BATs | BATs in Patients With Breast Cancer and Leptomeningeal Metastases | Terminated | USA | 0 |